发明名称 USE OF IRON FOR TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN
摘要 Use of iron to prepare a composition for preventative and/or curative treatment of attention deficit hyperactivity disorder (ADHD), or at least one of its symptoms, is new. Independent claims are also included for the following: (1) use of iron, combined with at least one psychostimulant (I), for simultaneous, separate or temporally staged use, to prepare a composition for preventative and/or curative treatment of nocturnal and/or diurnal motor hyperactivity and restless leg syndrome; and (2) in vitro prognosis and/or diagnosis (M1) of ADHD by determining the serum concentrations of ferritin and the soluble transferrin receptor. ACTIVITY : Nootropic; Neuroprotective; Tranquilizer; Antiparkinsonian; Anticonvulsant. No details of tests for these activities are given. MECHANISM OF ACTION : Replenishment of low iron reserves.
申请公布号 EP1635804(B1) 申请公布日期 2016.09.21
申请号 EP20040767222 申请日期 2004.06.01
申请人 NLS-1 PHARMA AG 发明人 KONOFAL, ERIC
分类号 A61K31/137;A61K31/138;A61K31/165;A61K31/198;A61K31/295;A61K31/4458;A61K33/26;A61K45/06;A61P25/00 主分类号 A61K31/137
代理机构 代理人
主权项
地址